NASDAQ:KRYS

Krystal Biotech (KRYS) News Today

$121.79

-2.41 (-1.94%)

(As of 06/5/2023 ET)

Compare

Today's Range: $120.46
▼
$127.02
50-Day Range: $78.48
▼
$124.20
52-Week Range: $49.17
▼
$127.02

Volume: 325,973 shs
Average Volume: 242,098 shs
Market Capitalization: $3.14 billion

P/E Ratio: N/A
Dividend Yield: N/A
Price Target: $134.00

Get Krystal Biotech News Delivered to You Automatically

KRYS Media Mentions By Week

KRYS Media Sentiment

Each headline receives a score ranging from 2 (good news) to -2 (bad news). Our company news sentiment scores track the average news sentiment of articles about each company over the most recent 7 days in order to identify companies that are receiving positive press.

KRYS
News Sentiment
▼
0.85

0.55
▲
Average
Medical
News Sentiment

KRYS News Coverage

We track news headlines from hundreds of news outlets and tag them by company. This chart compares the number of articles about this company in the last seven days compared with the average number of articles about this company on a typical week.

KRYS Articles
This Week
▼
9

4
▲
KRYS Articles
Average Week

Source

Source	Headline
	Krystal Biotech to Present at Upcoming Investor Conferences finance.yahoo.com - June 5 at 10:25 AM
	Credit Suisse AG Grows Position in Krystal Biotech, Inc. (NASDAQ:KRYS) marketbeat.com - June 5 at 9:20 AM
	Up 48% in 2023, Is This Biotech Stock a Buy? finance.yahoo.com - June 3 at 9:56 AM
	Krystal Biotech, Inc. (NASDAQ:KRYS) Insider Suma Krishnan Sells 25,000 Shares of Stock americanbankingnews.com - June 3 at 8:02 AM
	Thinking about buying stock in Krystal Biotech, Axsome Therapeutics, 89bio, Scpharmaceuticals, or Decibel Therapeutics? benzinga.com - June 2 at 8:24 PM
	Suma Krishnan Sells 25,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) Stock marketbeat.com - June 2 at 8:04 PM
	Mirae Asset Global Investments Co. Ltd. Takes Position in Krystal Biotech, Inc. (NASDAQ:KRYS) marketbeat.com - June 1 at 5:56 AM
	Krystal Clear: Krystal Biotech Clears Resistance in Good Volume marketbeat.com - May 30 at 7:38 AM
	Are Investors Undervaluing Krystal Biotech, Inc. (NASDAQ:KRYS) By 41%? finance.yahoo.com - May 29 at 4:05 PM
	Chardan Capital Weighs in on Krystal Biotech, Inc.'s FY2023 Earnings (NASDAQ:KRYS) americanbankingnews.com - May 27 at 2:36 AM
	Krystal Biotech (NASDAQ:KRYS) Price Target Increased to $145.00 by Analysts at Stifel Nicolaus americanbankingnews.com - May 26 at 6:28 AM
	Stifel Maintains Krystal Biotech (KRYS) Buy Recommendation msn.com - May 25 at 8:46 AM
	FY2023 Earnings Estimate for Krystal Biotech, Inc. (NASDAQ:KRYS) Issued By Chardan Capital marketbeat.com - May 25 at 6:35 AM
	Kathryn Romano Sells 25,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) Stock americanbankingnews.com - May 25 at 5:44 AM
	Daniel Janney Sells 50,000 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) Stock americanbankingnews.com - May 25 at 5:44 AM
	Kathryn Romano Sells 28,428 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) Stock americanbankingnews.com - May 25 at 5:44 AM
	Krystal Biotech, Inc. (NASDAQ:KRYS) Position Trimmed by Citigroup Inc. marketbeat.com - May 25 at 5:34 AM
	Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $139.00 americanbankingnews.com - May 25 at 4:14 AM
	FY2027 EPS Estimates for Krystal Biotech, Inc. Boosted by William Blair (NASDAQ:KRYS) americanbankingnews.com - May 25 at 2:30 AM
	Q3 2023 EPS Estimates for Krystal Biotech, Inc. (NASDAQ:KRYS) Raised by Analyst americanbankingnews.com - May 25 at 1:56 AM
	Option Care Health, Inc.: Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK finanznachrichten.de - May 24 at 7:42 AM
	Option Care, Amedisys in pact to offer Krystal Biotech’s skin disorder therapy msn.com - May 24 at 7:42 AM
	Krystal Biotech, Inc. (NASDAQ:KRYS) Forecasted to Post Q3 2023 Earnings of ($1.25) Per Share americanbankingnews.com - May 24 at 6:32 AM
	Q3 2023 Earnings Estimate for Krystal Biotech, Inc. (NASDAQ:KRYS) Issued By HC Wainwright marketbeat.com - May 24 at 6:00 AM
	HC Wainwright Increases Krystal Biotech (NASDAQ:KRYS) Price Target to $139.00 americanbankingnews.com - May 24 at 4:30 AM
	Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $118.00 americanbankingnews.com - May 24 at 2:34 AM
	Krystal Biotech (NASDAQ:KRYS) Shares Gap Up After Analyst Upgrade americanbankingnews.com - May 24 at 2:02 AM
	Option Care Health Selected by Krystal Biotech as Part of a Limited Distribution Specialty Pharmacy Network for VYJUVEK™ finance.yahoo.com - May 23 at 4:40 PM
	Goldman Sachs Maintains Krystal Biotech (KRYS) Buy Recommendation msn.com - May 23 at 6:39 AM
	B of A Securities Maintains Krystal Biotech (KRYS) Buy Recommendation msn.com - May 23 at 6:39 AM
	FY2027 EPS Estimates for Krystal Biotech, Inc. Raised by William Blair (NASDAQ:KRYS) marketbeat.com - May 23 at 6:25 AM
	Unlocking a $750 Million Opportunity: Krystal Biotech's Vyjuvek and its Potent Impact on Dystrophic Epidermolysis Bullosa Treatment msn.com - May 22 at 10:48 PM
	Krystal Biotech announces $160M private placement msn.com - May 22 at 5:48 PM
	CSafe Providing Sustainable Thermal Protection for Vyjuvek Gene Therapy from Krystal Biotech markets.businessinsider.com - May 22 at 5:48 PM
	Why Shares of Krystal Biotech Are Rising Monday finance.yahoo.com - May 22 at 5:48 PM
	Krystal Biotech Shares Rise 13% After $160M Private Placement Equity marketwatch.com - May 22 at 12:47 PM
	Analyst Expectations for Krystal Biotech's Future markets.businessinsider.com - May 22 at 12:47 PM
	FDA Approves First Redosable Gene Therapy, Krystal Biotech's Treatment For Skin Blistering Disorder finance.yahoo.com - May 22 at 12:47 PM
	Guggenheim Increases Krystal Biotech (NASDAQ:KRYS) Price Target to $130.00 americanbankingnews.com - May 22 at 9:24 AM
	Krystal Biotech (NASDAQ:KRYS) Price Target Raised to $148.00 americanbankingnews.com - May 22 at 8:30 AM
	Krystal Biotech Announces $160 Million Private Placement Equity Financing finance.yahoo.com - May 22 at 7:47 AM
	Victory Capital Management Inc. Buys 35,732 Shares of Krystal Biotech, Inc. (NASDAQ:KRYS) marketbeat.com - May 21 at 5:52 AM
	Krystal Biotech stock rises after FDA approves treatment for rare skin disease msn.com - May 20 at 11:12 PM
	U.S. FDA approves Krystal Biotech's skin-disorder gene therapy msn.com - May 20 at 11:12 PM
	Krystal gains FDA nod for topical gene therapy for rare skin disorder seekingalpha.com - May 19 at 10:09 PM
	Krystal Biotech Receives FDA Approval for the First-Ever Redosable Gene Therapy, VYJUVEK™ (beremagene geperpavec-svdt) for the Treatment of Dystrophic Epidermolysis Bullosa finance.yahoo.com - May 19 at 5:09 PM
	UPDATE 1-U.S. FDA approves Krystal Biotech's skin disorder gene therapy finance.yahoo.com - May 19 at 5:09 PM
	marketbeat.com - May 19 at 12:16 PM
	Krystal Biotech: A Promising Gene Therapy Innovator msn.com - May 18 at 4:06 PM
	Krystal Biotech, Inc. (NASDAQ:KRYS) Sees Large Decline in Short Interest americanbankingnews.com - May 17 at 4:10 AM

Get Krystal Biotech News Delivered to You Automatically

Related Companies and Tools

Related Companies:

Headlines Tools:

This page (NASDAQ:KRYS) was last updated on 6/6/2023 by MarketBeat.com Staff

Get 30 Days of MarketBeat All Access Free

Best-in-Class Portfolio Monitoring
View the latest news, buy/sell ratings, SEC filings and insider transactions for your stocks. Compare your portfolio performance to leading indices and get personalized stock ideas based on your portfolio.
Stock Ideas and Recommendations
Get daily stock ideas from top-performing Wall Street analysts. Get short term trading ideas from the MarketBeat Idea Engine. View which stocks are hot on social media with MarketBeat's trending stocks report.
Advanced Stock Screeners and Research Tools
Identify stocks that meet your criteria using seven unique stock screeners. See what's happening in the market right now with MarketBeat's real-time news feed. Export data to Excel for your own analysis.

Start Your 30-Day Free Trial

Krystal Biotech (KRYS) News Today

KRYS Media Mentions By Week

KRYS Media Sentiment

KRYS News Coverage

Related Companies and Tools

About MarketBeat

Popular Tools

Financial Calendars

Terms & Info